PAHO secretariat has developed a questionnaire to better understand the current scenario of the public health response to HTLV-1
The Pan American Health Organization/World Health Organization (PAHO/WHO) recognises the importance of Human T cell lymphotropic virus and its detrimental impact in patient`s health. In line with the inclusion of HTLV-1 in the WHO`s Global health sector strategies...
Orbituary Professor Luigi Chieco-Bianchi
The IRVA community, and the viral oncology research field in general, lost one of its precious contributors when Luigi Chieco-Bianchi died unexpectedly on June 23, 2023. We express our deepest sympathy to Luigi’s wife Anna Maria, their daughters Fulvia, Maria...New publication on antenatal screening for HTLV-1
Economic analysis of antenatal screening for human T-cell lymphotropic virus type 1 in Brazil: an open access cost-utility model Accompanying Commentary: Recommendations against breastfeeding require consultation with women for effective implementationExpression of interest to join 2 IRVA working parties
We are calling for Expressions of interest to join 2 IRVA working parties and encouraging representation from each country. There are 2 proposed working groups to be established: Testing Working GroupSurveillance Working Group The HTLV Surveillance Working Group will...Pharmaceuticals is promoting a special issue on “Drug Candidates Target HTLV-1 and HTLV-1-Related Diseases”
Special issue on HTLV